Shenouda Maged

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$312,649.11
Insider Sells Quantity
14
Insider Sells Sum
$1.26M

Insider Activity of Shenouda Maged

According to the SEC Form 4 filings, Shenouda Maged, being in a position of

  1. Chief Financial Officer at Relmada Therapeutics, Inc.,
    оver the last 12 months, has bought 86107 shares for $275,418, and sold 0 shares,
    over all time since 2015-12-14, has bought 92085 shares for $312,649, and sold 36000 shares for $1.26M.

The largest purchase of all time was on 2024-09-11 and amounted to 24120 shares of Relmada Therapeutics, Inc. for $71,154.

The largest sale of all time was on 2021-03-09 and amounted to 7527 shares of Relmada Therapeutics, Inc. for $267,693.

Biography of Shenouda Maged

No biography is available at this moment.

2024-09-11PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
24,120
0.0839%
$2.95$71,154+10.85%
2024-09-10PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
21,118
0.068%
$2.73$57,652+21%
2024-09-09PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
8,194
0.0248%
$2.55$20,895+21.86%
2024-01-31PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
6,875
0.0235%
$4.06$27,943-10.43%
2024-01-30PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
15,000
0.0491%
$3.89$58,323-9.95%
2024-01-29PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
10,800
0.035%
$3.65$39,450-6.12%
2021-03-10SaleRelmada Therapeutics, Inc.
RLMD
CFO
2,373
0.0144%
$35.11$83,313-27.16%
2021-03-09SaleRelmada Therapeutics, Inc.
RLMD
CFO
7,527
0.0464%
$35.56$267,693-27.03%
2021-03-08SaleRelmada Therapeutics, Inc.
RLMD
CFO
100
0.0006%
$35.00$3,500-26.29%
2021-02-24SaleRelmada Therapeutics, Inc.
RLMD
CFO
3,000
0.018%
$34.18$102,529-24.9%
2021-02-11SaleRelmada Therapeutics, Inc.
RLMD
CFO
1,428
0.0085%
$35.39$50,542-27.26%
2021-02-10SaleRelmada Therapeutics, Inc.
RLMD
CFO
2,410
0.0146%
$35.20$84,825-24.81%
2021-02-09SaleRelmada Therapeutics, Inc.
RLMD
CFO
5,359
0.0326%
$35.24$188,843-24.84%
2021-02-08SaleRelmada Therapeutics, Inc.
RLMD
CFO
3,603
0.0218%
$35.04$126,242-24.46%
2021-02-03SaleRelmada Therapeutics, Inc.
RLMD
CFO
100
0.0006%
$35.00$3,500-22.43%
2021-02-02SaleRelmada Therapeutics, Inc.
RLMD
CFO
3,100
0.0187%
$35.04$108,634-23.54%
2021-01-27SaleRelmada Therapeutics, Inc.
RLMD
CFO
3,000
0.0183%
$31.93$95,778-13.04%
2021-01-26SaleRelmada Therapeutics, Inc.
RLMD
CFO
607
0.0037%
$35.16$21,342-20.02%
2021-01-25SaleRelmada Therapeutics, Inc.
RLMD
CFO
1,280
0.0077%
$35.27$45,146-19.32%
2021-01-22SaleRelmada Therapeutics, Inc.
RLMD
CFO
2,113
0.0127%
$35.55$75,124-19%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.